A platform for oncogenomic reporting and interpretation.
Nature Communications
Reisle, Caralyn C; Williamson, Laura M LM; Pleasance, Erin E; Davies, Anna A; Pellegrini, Brayden B; Bleile, Dustin W DW; Mungall, Karen L KL; Chuah, Eric E; Jones, Martin R MR; Ma, Yussanne Y; Lewis, Eleanor E; Beckie, Isaac I; Pham, David D; Matiello Pletz, Raphael R; Muhammadzadeh, Amir A; Pierce, Brandon M BM; Li, Jacky J; Stevenson, Ross R; Wong, Hansen H; Bailey, Lance L; Reisle, Abbey A; Douglas, Matthew M; Bonakdar, Melika M; Nelson, Jessica M T JMT; Grisdale, Cameron J CJ; Krzywinski, Martin M; Fisic, Ana A; Mitchell, Teresa T; Renouf, Daniel J DJ; Yip, Stephen S; Laskin, Janessa J; Marra, Marco A MA; Jones, Steven J M SJM
The spliceosome pathway activity correlates with reduced anti-tumor immunity and immunotherapy response, and unfavorable clinical outcomes in pan-cancer.
Computational And Structural Biotechnology Journal
Chen, Zuobing Z; Chen, Canping C; Li, Lin L; Zhang, Tianfang T; Wang, Xiaosheng X
The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence.
British Journal Of Cancer
Rabbie, Roy R; Ferguson, Peter P; Wong, Kim K; Couturier, Dominique-Laurent DL; Moran, Una U; Turner, Clinton C; Emanuel, Patrick P; Haas, Kerstin K; Saunus, Jodi M JM; Davidson, Morgan R MR; Lakhani, Sunil R SR; Shivalingam, Brindha B; Long, Georgina V GV; Parkinson, Christine C; Osman, Iman I; Scolyer, Richard A RA; Corrie, Pippa P; Adams, David J DJ
Predicting clinical benefit of immunotherapy by antigenic or functional mutations affecting tumour immunogenicity.
Nature Communications
Kim, Kwoneel K; Kim, Hong Sook HS; Kim, Jeong Yeon JY; Jung, Hyunchul H; Sun, Jong-Mu JM; Ahn, Jin Seok JS; Ahn, Myung-Ju MJ; Park, Keunchil K; Lee, Se-Hoon SH; Choi, Jung Kyoon JK